From: Association of HIV infection with clinical and laboratory characteristics of sickle cell disease
HIV-positive (n = 15) | HIV-negative (n = 60) | P-value | |
---|---|---|---|
Characteristics | n (%) or mean ± SD | ||
Age (years)a | 30.0 ± 13.0 | 30.9 ± 13.5 | > 0.99 |
Gender | > 0.99 | ||
Male | 7 (47) | 28 (47) | |
Female | 8 (53) | 32 (53) | |
SCD genotype | > 0.99 | ||
Hb SS | 9 (60) | 36 (60) | |
Hb SC | 5 (33.3) | 20 (33.3) | |
Hb Sβ + −thalassemia | 1 (6.7) | 4 (6.7) | |
Hemocenter | 0.94 | ||
Hemorio | 9 (60) | 38 (63.3) | |
Hemominas-HBH | 4 (26.7) | 12 (20) | |
Hemominas-MOC | 1 (6.7) | 6 (10) | |
Hemope | 1 (6.7) | 4 (6.7) | |
Hydroxyurea therapy | 0.27 | ||
Yes | 1 (6.7) | 14 (23.3) | |
No | 14 (93.3) | 46 (46.7) | |
Chronic transfusion therapy | 0.63 | ||
Yes | 3 (20) | 7 (11.7) | |
No | 12 (80) | 53 (88.3) |